Council for europe portal
Language : en Search
Choose language

Newsroom

European Pharmacopoeia / General text/chapter | News | 24 January 2020 | Strasbourg, France
The new Pharmeuropa website is now online with a series of new features available to improve the user experience. As part of its efforts to enhance customer service and taking user feedback into account, the EDQM has redesigned the platform to include the following features: - single sign-on with other EDQM websites using the same authentication database, including Ph. Eur. online and PaedForm...
European Pharmacopoeia / Monograph | News | 21 January 2020 | Strasbourg, France
The European Pharmacopoeia (Ph. Eur.) 9th Edition has been obsolete since 1 January 2020. Consequently, the 9th Edition online and all previous versions, including the Ph. Eur. archives for 9th Edition clients, will no longer be accessible starting 1 March 2020. The Ph. Eur. 10th Edition and its supplements are available to subscribers on the dedicated European Pharmacopoeia online platform....
European Pharmacopoeia / Monograph | News | 16 January 2020 | Strasbourg, France
With a view to improving the correspondence between liquid chromatography column brand names (provided in the Knowledge Database) and the reagents used to describe the stationary phases for these columns, an overall review of all the monographs concerned has been launched. The names of the reagents and their definitions have also been reviewed to ensure that these stationary phases are described...
European Pharmacopoeia / Monograph | News | 16 January 2020 | Strasbourg, France
The European Pharmacopoeia Commission adopted a new monograph, on Rosuvastatin tablets (3008), at its 163rd session in March 2019. The monograph was published in Supplement 10.1 of the European Pharmacopoeia (Ph. Eur.), available since October 2019, and will become effective on 1 April 2020.
European Pharmacopoeia / Public enquiry | News | 07 January 2020 | Strasbourg, France
All new texts and texts that have undergone technical revisions are published in Pharmeuropa for public consultation. The deadline for comments on Pharmeuropa 32.1 is 31 March 2020. Users and interested parties are welcome to comment on these drafts. It should be noted that: • although draft monographs must not be regarded as official standards, they will, once adopted by the European...
Products and Services | News | 07 January 2020 | Strasbourg, France
The 10.2 supplement of the European Pharmacopoeia is now available and will be applicable in 38 European countries as of 1 July 2020.
European Pharmacopoeia / International harmonisation | News | 20 December 2019 | Strasbourg, France
The European Pharmacopoeia (Ph. Eur.) general chapter on Pharmacopoeial harmonisation (5.8) provides users with general guidance on the work of the EDQM in this field and details of the information included in harmonised Ph. Eur. general chapters and monographs. This information enables users to understand and correctly apply Ph. Eur. texts (monographs on excipients and general chapters)...
European Pharmacopoeia / General text/chapter | News | 19 December 2019 | Strasbourg, France
The European Pharmacopoeia (Ph. Eur.) has launched a public consultation on its new general chapter 2.8.26 on contaminant pyrrolizidine alkaloids. Users and concerned parties can submit their comments in Pharmeuropa 32.1 until 31 March 2020.
Paediatric Formulary | News | 18 December 2019 | Strasbourg, France
The EDQM is pleased to announce that the European Paediatric Formulary is now available free of charge on a dedicated online platform. This is a major achievement for the PaedForm Working Party and all the stakeholders involved, since it not only embodies several years’ work and dedication to the project, but feeds into the fundamental human right of equal access to quality healthcare.
European Pharmacopoeia / Monograph | News | 13 December 2019 | Strasbourg, France
The Ph. Eur. Commission proposes to revise the general monograph on Substances for pharmaceutical use (2034). This proposal has been made further to the European Commission referral C(2019)2698 of 2 April 2019 and the review initiated by the European Medicines Agency (EMA) in September 2019 under Article 5(3) of Regulation (EC) No. 726/2004 to provide guidance to marketing authorisation holders...
European Pharmacopoeia / Ph. Eur. Commission | News | 11 December 2019 | Strasbourg, France
During its 165th session, held in Strasbourg on 26 and 27 November 2019, the European Pharmacopoeia (Ph. Eur.) Commission (re)appointed more than 850 experts to its current 21 groups of experts and 39 active working parties for a new term running from November 2019 to November 2022.
European Pharmacopoeia / Ph. Eur. Commission | News | 10 December 2019 | Strasbourg, France
The European Pharmacopoeia (Ph. Eur.) Commission is undertaking a review of the dosage form monographs and related general chapters. Five different texts finalised by Ph. Eur. Group of Experts 12 have been launched for public consultation in Pharmeuropa 31.4 until 31 December 2019.
EDQM / All activities | News | 21 November 2019 | Strasbourg, France
As part of its efforts to improve customer service, the EDQM has developed a streamlined version of its HelpDesk and FAQs platform. The new HelpDesk was redesigned on the basis of feedback received from users and now benefits from a more intuitive interface, which is expected to enhance customer support and improve user experience.
European Pharmacopoeia / General text/chapter | News | 14 November 2019 | Strasbourg, France
The European Pharmacopoeia (Ph. Eur.) Commission is consulting its stakeholders on general chapter 2.4.20. Determination of elemental impurities. Updated in the context of discussions within the Pharmacopoeial Discussion Group (PDG), the text is intended to become the new harmonised standard for elemental impurities testing.
European Pharmacopoeia / International harmonisation | News | 07 November 2019 | Strasbourg, France
The EDQM will be holding the Meet the World Pharmacopoeias Symposium in February 2020 in Strasbourg, France, right after the 11th International Meeting of World Pharmacopoeias (IMWP). The aim of this event is to update stakeholders on the achievements and current work programme of the IMWP, giving participants an opportunity to exchange views on pharmacopoeial co-operation and harmonisation.